Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. Resverlogix Corp. leads the sector with a market cap of $21.78 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
Resverlogix Corp.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 901 |
Resverlogix Corp.
TO:RVX |
$21.78 Million | CA$30.11 Million | Canada | CA$0.10 | -5.00% | -5.00% | 940.74K |
| 902 |
Medicenna Therapeutics Corp
TO:MDNA |
$21.72 Million | CA$30.03 Million | Canada | CA$0.36 | +2.86% | +4.35% | 1.30 Million |
| 903 |
Elevation Oncology Inc
NASDAQ:ELEV |
$21.63 Million | $21.63 Million | USA | $0.37 | +0.00% | +0.00% | 4.82 Million |
| 904 |
SynCore Biotechnology Co Ltd
TWO:4192 |
$21.60 Million | NT$685.72 Million | Taiwan | NT$19.50 | +2.63% | +0.00% | 232.26K |
| 905 |
NanoViricides Inc
NYSE MKT:NNVC |
$21.57 Million | $21.57 Million | USA | $1.64 | +5.81% | -5.75% | 10.62 Million |
| 906 |
Longeveron LLC
NASDAQ:LGVN |
$21.15 Million | $21.15 Million | USA | $0.70 | +3.88% | +15.53% | 6.55 Million |
| 907 |
Neuphoria Therapeutics Inc
NASDAQ:NEUP |
$20.92 Million | $20.92 Million | USA | $3.88 | -1.02% | -1.02% | 9.99 Million |
| 908 |
VACCITECH (SP.ADR)/1
F:2AB |
$20.62 Million | €17.64 Million | Germany | €0.51 | +5.65% | +10.26% | 6.00K |
| 909 |
Skye Bioscience, Inc. Common Stock
NASDAQ:SKYE |
$19.98 Million | $19.98 Million | USA | $0.57 | -2.03% | -15.78% | 2.90 Million |
| 910 |
Tvardi Therapeutics, Inc.
NASDAQ:TVRD |
$19.70 Million | $19.70 Million | USA | $2.10 | +0.00% | -17.97% | 138.43 Million |
| 911 |
GridAI Technologies Corp.
NASDAQ:GRDX |
$19.64 Million | $19.64 Million | USA | $2.90 | -4.92% | -13.43% | 1.45 Million |
| 912 |
Gensight Biologics SA
PA:SIGHT |
$19.46 Million | €16.65 Million | France | €0.08 | -1.57% | -2.39% | 8.77 Million |
| 913 |
Urteste SA
WAR:URT |
$19.36 Million | zł70.35 Million | Poland | zł46.10 | +2.44% | +4.77% | 26.48K |
| 914 |
Alzinova AB
ST:ALZ |
$19.34 Million | Skr179.76 Million | Sweden | Skr1.16 | +14.17% | +54.67% | 281.10 Million |
| 915 |
Matricelf Ltd
TA:MTLF |
$19.21 Million | ILA7.16 Billion | Israel | ILA245.00 | -0.57% | -7.83% | 1.51 Million |
| 916 |
Marker Therapeutics Inc
NASDAQ:MRKR |
$18.84 Million | $18.84 Million | USA | $1.13 | +0.89% | -11.02% | 1.45 Million |
| 917 |
Allarity Therapeutics Inc
NASDAQ:ALLR |
$18.71 Million | $18.71 Million | USA | $1.21 | -1.63% | -0.82% | 2.31 Million |
| 918 |
Devonian Health Group Inc
V:GSD |
$18.61 Million | CA$25.72 Million | Canada | CA$9.25 | +8.82% | +2.78% | 29.78K |
| 919 |
Sensei Biotherapeutics Inc
NASDAQ:SNSE |
$18.59 Million | $18.59 Million | USA | $25.96 | -28.23% | +78.66% | 1.90 Million |
| 920 |
Celularity Inc
NASDAQ:CELU |
$18.32 Million | $18.32 Million | USA | $0.64 | -6.57% | -16.41% | 2.21 Million |
| 921 |
Noxopharm Ltd
AU:NOX |
$17.83 Million | AU$25.19 Million | Australia | AU$0.08 | +0.00% | -7.87% | 1.58 Million |
| 922 |
Atossa Genetics Inc
NASDAQ:ATOS |
$17.83 Million | $17.83 Million | USA | $2.07 | -5.48% | -14.11% | 2.62 Million |
| 923 |
Serina Therapeutics Inc
NYSE MKT:SER |
$17.80 Million | $17.80 Million | USA | $1.98 | +4.93% | +15.12% | 1.95 Million |
| 924 |
Dare Bioscience Inc
NASDAQ:DARE |
$17.76 Million | $17.76 Million | USA | $1.22 | -1.61% | -3.17% | 4.36 Million |
| 925 |
Genus PLC
LSE:GNS |
$17.73 Million | GBX145.71 Billion | UK | GBX2194.00 | -1.08% | +3.49% | 4.01 Million |
| 926 |
Lipocine Inc
NASDAQ:LPCN |
$17.48 Million | $17.48 Million | USA | $2.12 | +0.47% | -3.20% | 881.63K |
| 927 |
Algorae Pharmaceuticals Ltd
AU:1AI |
$17.18 Million | AU$24.28 Million | Australia | AU$0.01 | +0.00% | +0.00% | 23.76 Million |
| 928 |
Werewolf Therapeutics Inc
NASDAQ:HOWL |
$17.16 Million | $17.16 Million | USA | $0.35 | -29.44% | -1.97% | 23.21 Million |
| 929 |
Quince Therapeutics, Inc.
NASDAQ:QNCX |
$17.10 Million | $17.10 Million | USA | $23.39 | +1.56% | +27.95% | 1.62 Million |
| 930 |
Proteomics International Laboratories Ltd
AU:PIQ |
$16.95 Million | AU$23.95 Million | Australia | AU$0.15 | +0.00% | -14.71% | 13.91 Million |
| 931 |
Pharma Equity Group A/S Cl A
CO:PEG |
$16.90 Million | Dkr108.02 Million | Denmark | Dkr0.09 | +0.00% | +2.09% | 7.37 Million |
| 932 |
Initiator Pharma A/S
ST:INIT |
$16.80 Million | Skr156.07 Million | Sweden | Skr2.28 | +1.79% | -6.17% | 1.95 Million |
| 933 |
Neurosense Therapeutics Ltd
NASDAQ:NRSN |
$16.79 Million | $16.79 Million | USA | $0.47 | -2.27% | -28.98% | 7.80 Million |
| 934 |
Simris Alg AB (publ)
ST:SIMRIS-B |
$16.70 Million | Skr155.23 Million | Sweden | Skr0.12 | -10.51% | -10.85% | 6.65 Million |
| 935 |
Pluri Inc.
NASDAQ:PLUR |
$16.70 Million | $16.70 Million | USA | $1.55 | -0.64% | -13.65% | 1.03 Million |
| 936 |
Curis Inc
NASDAQ:CRIS |
$16.63 Million | $16.63 Million | USA | $5.02 | +1.21% | +7.49% | 38.65 Million |
| 937 |
Zivo Bioscience Inc
NASDAQ:ZIVO |
$16.61 Million | $16.61 Million | USA | $4.00 | +0.00% | -16.67% | 17.19K |
| 938 |
Genenta Science SpA ADR
NASDAQ:GNTA |
$16.45 Million | $16.45 Million | USA | $0.70 | -1.69% | -1.63% | 2.38 Million |
| 939 |
Aelis Farma SA
PA:AELIS |
$16.32 Million | €13.96 Million | France | €1.02 | -0.19% | -2.48% | 375.35K |
| 940 |
Mgenplus Co. Ltd.
KQ:032790 |
$16.13 Million | ₩23.81 Billion | Korea | ₩927.00 | -4.63% | -7.76% | 3.33 Million |
| 941 |
EZZ Life Science Holdings Ltd
AU:EZZ |
$15.98 Million | AU$22.58 Million | Australia | AU$0.48 | +3.23% | -3.03% | 382.34K |
| 942 |
Genolution Inc.
KQ:225220 |
$15.87 Million | ₩23.41 Billion | Korea | ₩1296.00 | -0.92% | -0.69% | 1.10 Million |
| 943 |
Nanologica AB
ST:NICA |
$15.71 Million | Skr145.97 Million | Sweden | Skr0.44 | -2.84% | +3.26% | 9.92 Million |
| 944 |
Daesung Microbiological Labs. Co. Ltd
KQ:036480 |
$15.71 Million | ₩23.18 Billion | Korea | ₩6100.00 | -0.16% | -6.30% | 357.61K |
| 945 |
Hoth Therapeutics Inc
NASDAQ:HOTH |
$15.67 Million | $15.67 Million | USA | $0.82 | -7.93% | -36.49% | 522.03 Million |
| 946 |
Citius Pharmaceuticals Inc
NASDAQ:CTXR |
$15.65 Million | $15.65 Million | USA | $0.57 | -9.81% | +7.28% | 9.66 Million |
| 947 |
Defence Therapeutics Inc.
F:DTC |
$15.29 Million | €13.08 Million | Germany | €0.23 | -0.87% | -3.39% | 70.00K |
| 948 |
CHEMOMAB THERAP. ADR/20
F:2QV0 |
$15.26 Million | €13.05 Million | Germany | €2.94 | +300.00% | +269.81% | 30.70K |
| 949 |
BTC Health Ltd
AU:BTC |
$15.18 Million | AU$21.45 Million | Australia | AU$0.06 | +13.21% | +13.21% | 167.51K |
| 950 |
Neurotech International Ltd
AU:NTI |
$14.92 Million | AU$21.08 Million | Australia | AU$0.02 | +0.00% | -11.11% | 44.59 Million |
| 951 |
Applied Therapeutics Inc
NASDAQ:APLT |
$14.86 Million | $14.86 Million | USA | $0.10 | +0.00% | +6.96% | 245.46 Million |
| 952 |
Diamyd Medical AB (publ)
ST:DMYD-B |
$14.85 Million | Skr138.02 Million | Sweden | Skr1.03 | +0.00% | +0.00% | 9.98 Million |
| 953 |
OSR Holdings Inc
NASDAQ:OSRH |
$14.84 Million | $14.84 Million | USA | $0.45 | +4.19% | -0.44% | 16.82 Million |
| 954 |
Biovica International AB (publ)
ST:BIOVIC-B |
$14.81 Million | Skr137.64 Million | Sweden | Skr0.50 | -3.47% | +2.04% | 17.77 Million |
| 955 |
NextCure Inc
NASDAQ:NXTC |
$14.53 Million | $14.53 Million | USA | $4.15 | -17.59% | -0.84% | 127.51 Million |
| 956 |
Medifron DBT Co. Ltd
KQ:065650 |
$14.48 Million | ₩21.36 Billion | Korea | ₩1605.00 | +8.74% | -21.32% | 320.72K |
| 957 |
Xintela AB
ST:XINT |
$14.31 Million | Skr132.93 Million | Sweden | Skr0.19 | +0.27% | +0.27% | 5.90 Million |
| 958 |
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC |
$14.25 Million | $14.25 Million | USA | $6.37 | -5.98% | -17.18% | 2.26 Million |
| 959 |
GENENTA SCIENCE(SP.ADR)/1
F:K5F |
$14.25 Million | €12.18 Million | Germany | €0.52 | +0.00% | +10.17% | 15.96K |
| 960 |
Passage Bio Inc
NASDAQ:PASG |
$14.21 Million | $14.21 Million | USA | $4.47 | -0.45% | -8.78% | 1.09 Million |
| 961 |
Neuroscientific Biopharmaceuticals Ltd
AU:NSB |
$14.12 Million | AU$19.95 Million | Australia | AU$0.06 | +0.00% | -7.69% | 5.14 Million |
| 962 |
Argenica Therapeutics Ltd
AU:AGN |
$14.09 Million | AU$19.91 Million | Australia | AU$0.16 | +3.33% | +3.33% | 7.45 Million |
| 963 |
Kala Pharmaceuticals Inc
NASDAQ:KALA |
$14.05 Million | $14.05 Million | USA | $0.76 | +3.59% | +23.86% | 4.16 Million |
| 964 |
Palatin Technologies, Inc. Common Stock
NASDAQ:PTN |
$13.70 Million | $13.70 Million | USA | $7.70 | -1.41% | -4.16% | 458.41K |
| 965 |
Biotechnology Assets S.A.
MC:BST |
$13.52 Million | €11.57 Million | Spain | €0.22 | +6.90% | +4.33% | 3.94 Million |
| 966 |
NextCell Pharma AB
ST:NXTCL |
$13.50 Million | Skr125.43 Million | Sweden | Skr1.13 | +1.26% | +11.26% | 7.57 Million |
| 967 |
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB |
$13.46 Million | $13.46 Million | USA | $0.33 | +0.00% | +10.00% | 8.79K |
| 968 |
Oxford Nanopore Technologies Ltd
LSE:ONT |
$13.42 Million | GBX110.28 Billion | UK | GBX113.40 | -0.44% | +5.29% | 27.38 Million |
| 969 |
Poxel SA
PA:POXEL |
$13.14 Million | €11.24 Million | France | €0.21 | +3.97% | +4.75% | 2.41 Million |
| 970 |
Jasper Therapeutics Inc
NASDAQ:JSPR |
$13.05 Million | $13.05 Million | USA | $0.63 | +1.48% | -13.59% | 49.31 Million |
| 971 |
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ:CVKD |
$12.93 Million | $12.93 Million | USA | $5.53 | -5.63% | +14.97% | 1.28 Million |
| 972 |
Cyclerion Therapeutics Inc
NASDAQ:CYCN |
$12.90 Million | $12.90 Million | USA | $3.44 | -1.71% | -4.97% | 485.92K |
| 973 |
NFL Biosciences SAS
PA:ALNFL |
$12.89 Million | €11.02 Million | France | €0.87 | +2.72% | +4.82% | 308.46K |
| 974 |
PROBIOTIX HEALTH LS-05
F:X90 |
$12.76 Million | €10.91 Million | Germany | €0.07 | +0.00% | -0.72% | 0.00 |
| 975 |
Tempest Therapeutics Inc
NASDAQ:TPST |
$12.68 Million | $12.68 Million | USA | $0.86 | -0.86% | -8.96% | 3.93 Million |
| 976 |
SeaStar Medical Holding Corporation
NASDAQ:ICU |
$12.51 Million | $12.51 Million | USA | $3.13 | -1.57% | -16.31% | 2.44 Million |
| 977 |
Elicera Therapeutics AB
ST:ELIC |
$12.48 Million | Skr116.00 Million | Sweden | Skr2.39 | +4.14% | -7.90% | 6.90 Million |
| 978 |
BioLineRx Ltd
NASDAQ:BLRX |
$12.27 Million | $12.27 Million | USA | $2.82 | +4.44% | -1.40% | 454.00K |
| 979 |
Biocardia Inc
NASDAQ:BCDA |
$12.27 Million | $12.27 Million | USA | $0.82 | +6.89% | -8.93% | 8.86 Million |
| 980 |
IRLAB Therapeutics AB (publ)
ST:IRLAB-A |
$12.04 Million | Skr111.84 Million | Sweden | Skr1.32 | +1.23% | +3.45% | 10.54 Million |
| 981 |
CEL-SCI Corp
NYSE MKT:CVM |
$12.01 Million | $12.01 Million | USA | $1.42 | -2.07% | +9.23% | 17.92 Million |
| 982 |
Lunai Bioworks Inc.
NASDAQ:LNAI |
$11.97 Million | $11.97 Million | USA | $1.94 | -3.96% | -16.38% | 1.03 Million |
| 983 |
Vyome Holdings, Inc.
NASDAQ:HIND |
$11.94 Million | $11.94 Million | USA | $2.12 | +5.22% | -1.17% | 307.49K |
| 984 |
Phio Pharmaceuticals Corp
NASDAQ:PHIO |
$11.91 Million | $11.91 Million | USA | $1.03 | -0.49% | -4.21% | 31.16 Million |
| 985 |
COCRYSTAL PHARMA NEW O.N.
F:8CC |
$11.85 Million | €10.13 Million | Germany | €0.74 | -5.77% | -6.96% | 0.00 |
| 986 |
Polyrizon Ltd. Ordinary Shares
NASDAQ:PLRZ |
$11.72 Million | $11.72 Million | USA | $11.25 | -3.18% | -26.52% | 1.27 Million |
| 987 |
Opthea Ltd
AU:OPT |
$11.62 Million | AU$16.42 Million | Australia | AU$0.01 | +0.00% | +0.00% | 168.16 Million |
| 988 |
GENFLOW BIOSCIENCES PLC
F:WQ5 |
$11.59 Million | €9.91 Million | Germany | €0.02 | +2.78% | -9.76% | 0.00 |
| 989 |
ABERA BIOSCIENCE AB
F:8WK |
$11.56 Million | €9.89 Million | Germany | €0.72 | +1.12% | +1.69% | 0.00 |
| 990 |
Hookipa Pharma Inc
NASDAQ:HOOK |
$11.47 Million | $11.47 Million | USA | $1.15 | +0.00% | +0.00% | 48.02K |
| 991 |
Biovie Inc
NASDAQ:BIVI |
$11.46 Million | $11.46 Million | USA | $1.52 | +6.29% | +5.56% | 4.95 Million |
| 992 |
Cocrystal Pharma Inc
NASDAQ:COCP |
$11.31 Million | $11.31 Million | USA | $0.82 | -5.50% | -10.88% | 698.15K |
| 993 |
Sirona Biochem Corp
V:SBM |
$11.23 Million | CA$15.53 Million | Canada | CA$0.06 | +0.00% | +0.00% | 0.00 |
| 994 |
Chemomab Therapeutics Ltd DRC
NASDAQ:CMMB |
$11.16 Million | $11.16 Million | USA | $1.55 | +1.31% | +10.71% | 6.11 Million |
| 995 |
Quantum BioPharma Ltd.
NASDAQ:QNTM |
$11.11 Million | $11.11 Million | USA | $2.89 | +1.76% | +1.76% | 2.06 Million |
| 996 |
Bioleaders Corporation
KQ:142760 |
$11.06 Million | ₩16.32 Billion | Korea | ₩387.00 | +6.61% | +2.11% | 10.00 Million |
| 997 |
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ:GDTC |
$11.01 Million | $11.01 Million | USA | $0.93 | -5.99% | +5.69% | 3.96 Million |
| 998 |
Cellectar Biosciences Inc
NASDAQ:CLRB |
$10.90 Million | $10.90 Million | USA | $2.57 | +1.58% | +4.05% | 2.42 Million |
| 999 |
Clal Biotechnology Industries Ltd
TA:CBI |
$10.72 Million | ILA4.00 Billion | Israel | ILA25.50 | -0.78% | -5.56% | 1.35 Million |
| 1000 |
Portage Biotech Inc
NASDAQ:PRTG |
$10.71 Million | $10.71 Million | USA | $4.70 | -0.84% | -10.13% | 35.48 Million |
| 1001 |
Kiora Pharmaceuticals Inc
NASDAQ:KPRX |
$10.68 Million | $10.68 Million | USA | $2.56 | +0.20% | +2.40% | 465.43K |
| 1002 |
GT Biopharma Inc
NASDAQ:GTBP |
$10.58 Million | $10.58 Million | USA | $0.29 | -4.65% | -12.44% | 20.10 Million |
| 1003 |
BioLine RX Ltd
TA:BLRX |
$10.50 Million | ILA3.92 Billion | Israel | ILA1.50 | -6.25% | -6.25% | 66.19 Million |
| 1004 |
Eterna Therapeutics Inc
NASDAQ:ERNA |
$10.38 Million | $10.38 Million | USA | $3.28 | -5.48% | -17.79% | 27.71 Million |
| 1005 |
Pasithea Therapeutics Corp
NASDAQ:KTTA |
$10.30 Million | $10.30 Million | USA | $0.46 | +3.58% | -4.23% | 34.24 Million |
| 1006 |
Exicure Inc
NASDAQ:XCUR |
$10.20 Million | $10.20 Million | USA | $1.60 | +1.91% | -6.43% | 23.46 Million |
| 1007 |
In8bio Inc
NASDAQ:INAB |
$10.19 Million | $10.19 Million | USA | $1.04 | -4.17% | -13.03% | 1.24 Million |
| 1008 |
GlycoMimetics Inc
NASDAQ:GLYC |
$10.13 Million | $10.13 Million | USA | $0.16 | +0.00% | +0.00% | 1.07 Million |
| 1009 |
Oncozenge AB
ST:ONCOZ |
$9.93 Million | Skr92.30 Million | Sweden | Skr6.57 | -3.38% | -8.11% | 511.95K |
| 1010 |
Intensity Therapeutics, Inc. Common stock
NASDAQ:INTS |
$9.92 Million | $9.92 Million | USA | $4.15 | +2.47% | -6.32% | 1.04 Million |
| 1011 |
CalciMedica, Inc. Common Stock
NASDAQ:CALC |
$9.90 Million | $9.90 Million | USA | $1.00 | +19.05% | +39.68% | 10.27 Million |
| 1012 |
VistaGen Therapeutics Inc
NASDAQ:VTGN |
$9.89 Million | $9.89 Million | USA | $0.24 | +0.00% | +6.64% | 88.36 Million |
| 1013 |
Shenzhen CAU Technology Co Ltd
SHE:000004 |
$9.88 Million | CN¥67.51 Million | China | CN¥0.51 | +10.87% | +13.33% | 151.25 Million |
| 1014 |
Orgenesis Inc
NASDAQ:ORGS |
$9.83 Million | $9.83 Million | USA | $1.95 | +0.00% | +0.00% | 2.56K |
| 1015 |
Biomind Labs Inc
NEO:BMND |
$9.70 Million | CA$13.40 Million | Canada | CA$0.20 | -17.02% | +680.00% | 106.93K |
| 1016 |
Lexaria Bioscience Corp
NASDAQ:LEXX |
$9.69 Million | $9.69 Million | USA | $0.39 | -1.34% | -31.43% | 2.68 Million |
| 1017 |
Theriva Biologics Inc.
NYSE MKT:TOVX |
$9.64 Million | $9.64 Million | USA | $0.21 | -0.05% | -3.23% | 51.81 Million |
| 1018 |
Entero Therapeutics, Inc.
NASDAQ:ENTO |
$9.58 Million | $9.58 Million | USA | $2.85 | -5.32% | -13.11% | 3.88 Million |
| 1019 |
Adaptimmune Therapeutics Plc
NASDAQ:ADAP |
$9.54 Million | $9.54 Million | USA | $0.04 | -29.13% | -50.34% | 2.65 Billion |
| 1020 |
Zhuhai Sailong Pharmaceutical Co Ltd
SHE:002898 |
$9.53 Million | CN¥65.12 Million | China | CN¥0.37 | -2.63% | +8.82% | 140.79 Million |
| 1021 |
ESSA Pharma Inc
NASDAQ:EPIX |
$9.52 Million | $9.52 Million | USA | $0.20 | -1.85% | +5.34% | 77.22 Million |
| 1022 |
Pharmena S.A.
WAR:PHR |
$9.44 Million | zł34.30 Million | Poland | zł3.08 | +0.00% | -2.53% | 27.65K |
| 1023 |
Annexin Pharmaceuticals AB
ST:ANNX |
$9.31 Million | Skr86.47 Million | Sweden | Skr12.25 | -5.77% | -2.00% | 176.46K |
| 1024 |
OPTHEA LTD
F:UKJ |
$9.28 Million | €7.93 Million | Germany | €0.01 | +1.75% | -17.14% | 0.00 |
| 1025 |
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI |
$9.16 Million | $9.16 Million | USA | $0.90 | +0.00% | -10.00% | 414.12K |
| 1026 |
AEON Biopharma, Inc.
NYSE MKT:AEON |
$9.05 Million | $9.05 Million | USA | $0.78 | -5.38% | -3.00% | 1.85 Million |
| 1027 |
Celyad SA
BR:CYAD |
$8.95 Million | €7.66 Million | Belgium | €0.26 | -3.69% | -1.14% | 345.12K |
| 1028 |
Senti Biosciences Inc
NASDAQ:SNTI |
$8.95 Million | $8.95 Million | USA | $0.34 | -5.52% | -20.18% | 7.91 Million |
| 1029 |
Quoin Pharmaceuticals Ltd DRC
NASDAQ:QNRX |
$8.94 Million | $8.94 Million | USA | $4.45 | +1.14% | +1.83% | 774.70K |
| 1030 |
Chromocell Therapeutics Corporation
NYSE MKT:CHRO |
$8.90 Million | $8.90 Million | USA | $22.46 | -5.03% | -0.18% | 182.56K |
| 1031 |
XTL Biopharmaceuticals Ltd ADR
NASDAQ:XTLB |
$8.80 Million | $8.80 Million | USA | $2.45 | -2.59% | +2.73% | 282.27K |
| 1032 |
Lisata Therapeutics Inc.
NASDAQ:LSTA |
$8.73 Million | $8.73 Million | USA | $0.99 | -3.88% | -53.30% | 2.43 Million |
| 1033 |
COSCIENS Biopharma Inc.
NASDAQ:CSCI |
$8.64 Million | $8.64 Million | USA | $7.10 | -0.70% | -6.82% | 38.64K |
| 1034 |
Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN |
$8.60 Million | $8.60 Million | USA | $1.26 | -59.35% | -72.31% | 27.78 Million |
| 1035 |
BioLight Life Sciences Ltd
TA:BOLT |
$8.56 Million | ILA3.19 Billion | Israel | ILA353.00 | -8.76% | -17.98% | 410.39K |
| 1036 |
Immuron Ltd
AU:IMC |
$8.32 Million | AU$11.76 Million | Australia | AU$0.04 | +5.88% | -5.26% | 2.98 Million |
| 1037 |
Cambium Bio Ltd
AU:CMB |
$8.32 Million | AU$11.75 Million | Australia | AU$0.43 | +0.00% | +0.00% | 24.20K |
| 1038 |
Spago Nanomedical AB
ST:SPAGO |
$8.29 Million | Skr77.07 Million | Sweden | Skr0.12 | -1.69% | +0.43% | 8.34 Million |
| 1039 |
LISATA THERAP.INC.DL-001
F:8NE |
$8.25 Million | €7.06 Million | Germany | €0.78 | -6.63% | -56.70% | 0.00 |
| 1040 |
Oxford BioMedica PLC
LSE:OXB |
$8.23 Million | GBX67.62 Billion | UK | GBX560.00 | -0.88% | -4.11% | 9.78 Million |
| 1041 |
Turnstone Biologics Corp. Common Stock
NASDAQ:TSBX |
$8.21 Million | $8.21 Million | USA | $0.36 | +0.00% | +0.00% | 1.48 Million |
| 1042 |
Hemostemix Inc
V:HEM |
$8.18 Million | CA$11.31 Million | Canada | CA$0.06 | +0.00% | +0.00% | 744.55K |
| 1043 |
Scandinavian ChemoTech AB Series B
ST:CMOTEC-B |
$8.09 Million | Skr75.22 Million | Sweden | Skr3.16 | -12.22% | -16.84% | 202.48K |
| 1044 |
Visgeneer
TWO:4197 |
$8.09 Million | NT$256.84 Million | Taiwan | NT$8.51 | +0.47% | -6.48% | 640.34K |
| 1045 |
Synaptogenix Inc
NASDAQ:SNPX |
$8.09 Million | $8.09 Million | USA | $5.82 | -11.08% | -9.77% | 5.67 Million |
| 1046 |
AcouSort AB
ST:ACOU |
$8.04 Million | Skr74.71 Million | Sweden | Skr3.53 | +1.44% | -0.56% | 406.06K |
| 1047 |
Bergenbio ASA
OL:BGBIO |
$7.75 Million | Nkr73.62 Million | Norway | Nkr0.47 | -5.91% | -61.29% | 13.59 Million |
| 1048 |
Aprea Therapeutics Inc
NASDAQ:APRE |
$7.68 Million | $7.68 Million | USA | $0.62 | -2.36% | -1.74% | 1.50 Million |
| 1049 |
Bolt Biotherapeutics
NASDAQ:BOLT |
$7.67 Million | $7.67 Million | USA | $3.99 | +2.57% | +4.72% | 424.25K |
| 1050 |
Curative Biotechnology Inc
NYSE MKT:CUBT |
$7.66 Million | $7.66 Million | USA | $1.30 | +30.00% | -10.34% | 17.75K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries